Atrial fibrillation and stroke: what we know, what's new, and what we should do now.
作者信息
Landefeld C S
出版信息
CMAJ. 1997 Sep 15;157(6):695-7.
Abstract
摘要
相似文献
1
Atrial fibrillation and stroke: what we know, what's new, and what we should do now.心房颤动与中风：我们所知道的、新进展以及我们现在该做的。
CMAJ. 1997 Sep 15;157(6):695-7.
2
Re: CJ Green, DC Hadorn, K Bassett, A Kazanjian. Anticoagulation in chronic nonvalvular atrial fibrillation: a critical appraisal and meta-analysis. 1997;13:811-5.回复：CJ·格林、DC·哈多恩、K·巴塞特、A·卡赞吉安。慢性非瓣膜性心房颤动的抗凝治疗：一项批判性评价与荟萃分析。1997年；13:811 - 815。
Can J Cardiol. 1998 May;14(5):659, 662; author reply 663, 665.
3
4
Warfarin versus aspirin in the elderly in primary prophylaxis for atrial fibrillation.华法林与阿司匹林用于老年患者心房颤动一级预防的比较
Age Ageing. 2007 Mar;36(2):117-9. doi: 10.1093/ageing/afl181. Epub 2007 Jan 25.
5
6
Underuse of warfarin in atrial fibrillation.心房颤动中华法林的使用不足。
Arch Intern Med. 1997 Jul 14;157(13):1505.
7
Stroke prevention in non-rheumatic atrial fibrillation.
Tenn Med. 1997 Jan;90(1):21-2.
8
Anticoagulation for stroke prevention in a Medicare population with atrial fibrillation.医疗保险参保房颤人群中预防卒中的抗凝治疗。
J Fla Med Assoc. 1997 Apr-May;84(4):227-31.
9
Atrial fibrillation and stroke. Three new studies, three remaining questions.心房颤动与中风。三项新研究，三个遗留问题。
Arch Intern Med. 1994 Jul 11;154(13):1443-8.
10
Atrial fibrillation quality improvement.心房颤动质量改进
J Miss State Med Assoc. 1997 Oct;38(10):388-9.
本文引用的文献
1
Why isn't warfarin prescribed to patients with nonrheumatic atrial fibrillation?为什么不将华法林用于非风湿性心房颤动患者？
J Gen Intern Med. 1996 Dec;11(12):721-8. doi: 10.1007/BF02598985.
2
Failure to prescribe warfarin to patients with nonrheumatic atrial fibrillation.
J Gen Intern Med. 1996 Dec;11(12):713-20. doi: 10.1007/BF02598984.
3
Plasma fibrinogen and fibrin D-dimer in patients with atrial fibrillation: effects of cardioversion to sinus rhythm.心房颤动患者的血浆纤维蛋白原和纤维蛋白D - 二聚体：转复为窦性心律的影响
Int J Cardiol. 1995 Oct;51(3):245-51. doi: 10.1016/0167-5273(95)02434-x.
4
Survey of use of anticoagulation in patients with atrial fibrillation.心房颤动患者抗凝治疗使用情况调查。
BMJ. 1993 Oct 23;307(6911):1045. doi: 10.1136/bmj.307.6911.1045.
5
Anticoagulation in atrial fibrillation. Does efficacy in clinical trials translate into effectiveness in practice?
Arch Intern Med. 1994 Sep 12;154(17):1945-53. doi: 10.1001/archinte.154.17.1945.
6
Anticoagulants for atrial fibrillation.用于心房颤动的抗凝剂。
Lancet. 1993 Nov 20;342(8882):1251-2. doi: 10.1016/0140-6736(93)92353-u.
7
Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications.心房颤动患者的患病率、年龄分布及性别。分析与启示。
Arch Intern Med. 1995 Mar 13;155(5):469-73.
8
Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment.慢性心房颤动中血栓形成标志物增加：华法林治疗的影响。
Br Heart J. 1995 Jun;73(6):527-33. doi: 10.1136/hrt.73.6.527.
9
10
Does atrial fibrillation confer a hypercoagulable state?心房颤动是否会导致高凝状态？
Lancet. 1995 Nov 18;346(8986):1313-4. doi: 10.1016/s0140-6736(95)92339-x.
Zotero 插件